Literature DB >> 14531573

Glioma invasion--pattern of dissemination by mechanisms of invasion and surgical intervention, pattern of gene expression and its regulatory control by tumorsuppressor p53 and proto-oncogene ETS-1.

A Giese1.   

Abstract

The capacity of glioma cells to invade normal brain leads to far reaching dissemination of these tumors limiting surgical resection and the prospect of local treatment strategies. The analysis of the dissemination pattern, the molecular substrates and mechanisms involved suggest that glioma invasion most likely represents independent cellular behaviors leading to distinct pattern of spread. The search for common denominators of the invasive phenotype has demonstrated that invasive cells show gene expression profiles indicating elevated expression of motility associated genes and genes involved in resistance to apoptosis whereas proliferation and apoptosis related gene expression is repressed. Confirming these findings, invasive cells in vitro show elevated motility and resistance to drug induced apoptosis. Obviously invasiveness is an early event in the progression of glial tumors. Therefore, the loss of control over invasion genes must involve key elements of molecular tumor progression. We have recently demonstrated that deregulation of invasion gene expression occurs as a consequence of functional impairment of tumor suppressor p53 leading to unrestrained activation of proto-oncogene Ets-1 dependent invasion-associated genes. In this article the prospect of limiting the dissemination of glial tumors by anti-invasive strategies and targets for modulation of the invasive phenotype to reconstitute chemo- and radiation sensitivity are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531573     DOI: 10.1007/978-3-7091-6090-9_21

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  25 in total

1.  Post-translational Modifications of OLIG2 Regulate Glioma Invasion through the TGF-β Pathway.

Authors:  Shiv K Singh; Roberto Fiorelli; Robert Kupp; Sindhu Rajan; Emily Szeto; Costanza Lo Cascio; Cecile L Maire; Yu Sun; John A Alberta; Jennifer M Eschbacher; Keith L Ligon; Michael E Berens; Nader Sanai; Shwetal Mehta
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

2.  Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.

Authors:  Dominique B Hoelzinger; Luigi Mariani; Joachim Weis; Tanja Woyke; Theresa J Berens; Wendy S McDonough; Andrew Sloan; Stephen W Coons; Michael E Berens
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

3.  S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells.

Authors:  Elena Capoccia; Carla Cirillo; Annalisa Marchetto; Samanta Tiberi; Youssef Sawikr; Marcella Pesce; Alessandra D'Alessandro; Caterina Scuderi; Giovanni Sarnelli; Rosario Cuomo; Luca Steardo; Giuseppe Esposito
Journal:  Oncol Lett       Date:  2015-04-01       Impact factor: 2.967

4.  Bioluminescence imaging of invasive intracranial xenografts: implications for translational research and targeted therapeutics of brain tumors.

Authors:  Eduard B Dinca; Ramona V Voicu; Alexandru V Ciurea
Journal:  Neurosurg Rev       Date:  2010-07-23       Impact factor: 3.042

5.  Modulation of p75 neurotrophin receptor under hypoxic conditions induces migration and invasion of C6 glioma cells.

Authors:  Ting-Chung Wang; Sheng-Jie Luo; Chun-Liang Lin; Pey-Jium Chang; Miao-Fen Chen
Journal:  Clin Exp Metastasis       Date:  2014-12-20       Impact factor: 5.150

6.  Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.

Authors:  Antonietta Arcella; Giulia Carpinelli; Giuseppe Battaglia; Mara D'Onofrio; Filippo Santoro; Richard Teke Ngomba; Valeria Bruno; Paola Casolini; Felice Giangaspero; Ferdinando Nicoletti
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

7.  Overexpression of CD99 Increases the Migration and Invasiveness of Human Malignant Glioma Cells.

Authors:  Ho Jun Seol; Jong Hee Chang; Junkoh Yamamoto; Rocco Romagnuolo; Youngchul Suh; Adrienne Weeks; Sameer Agnihotri; Christian A Smith; James T Rutka
Journal:  Genes Cancer       Date:  2012-09

8.  Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors.

Authors:  Masayuki Kanamori; Toshihiro Kumabe; Yukihiko Sonoda; Yoshikazu Nishino; Mika Watanabe; Teiji Tominaga
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

9.  Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.

Authors:  Sonja Mertsch; Leon J Schurgers; Kathrin Weber; Werner Paulus; Volker Senner
Journal:  BMC Cancer       Date:  2009-08-27       Impact factor: 4.430

10.  Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imaging.

Authors:  Shulun Nie; Yufang Zhu; Jia Yang; Tao Xin; Song Xue; Xianbin Zhang; Jujie Sun; Dianbin Mu; Yongsheng Gao; Zhaoqiu Chen; Xingchen Ding; Jinming Yu; Man Hu
Journal:  Radiat Oncol       Date:  2021-06-07       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.